Hide Board Information

Show Board Information

Stocks In The Spotlight

Board Mod: stockstallion

Asst Mods:

Last Post: 09/09/2025 2:49:37 PM

Board Marks: 53

Posts Today: 0

Board Views Today: 396

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

150	Please don't forget to MARK THE BOARD !!!	stockstallion	03/03/2012 9:55:59 PM
680	ATTENTION Investors/Traders: Looking for people	stockstallion	10/16/2012 12:16:22 AM
707	LOOKING for CTLE to make a nice leap forward!	stockstallion	12/16/2012 5:22:27 PM
8	Board Marked	bra1loga	02/20/2012 8:08:50 AM
7	I have the same problem..can only work (and	junewong	02/19/2012 6:01:55 PM
6	EMWW is on my radar next week. (Provided  my	Roger Wilco	02/19/2012 5:58:56 PM
5	sign up for board alerts,don't miss out on the	stockstallion	02/19/2012 5:44:23 PM
4	EMWW..on high alert	junewong	02/19/2012 5:41:23 PM
3	Nice board..marked	junewong	02/19/2012 5:40:33 PM
2	HRAL is going to rock on Tuesday!	the outlaw	02/19/2012 5:18:57 PM

Newer

Recent Articles

• Dr. Steven Walker Joins Advanced Technology International Board
• Middlefield Innovation Dividend ETF: Exciting Q4 2025 Distributions
• Investigation into Core Scientific's Proposed Acquisition Insights
• Park Ha Biological Technology Co., Ltd. Changes Ticker to BYAH
• Amazon's AWS Apology: Insights into Global Outage Impact
• Middlefield Real Estate Fund Announces Upcoming Distributions
• Upcoming Distributions for MINT Income Fund Unitholders
• Exciting Updates on Middlefield Global Infrastructure ETF Distributions
• Understanding Centene Corp's Market Position and Sentiment
• Class Action Lawsuit Against Savara Inc. (SVRA) Explained
• Gartner Inc's Short Interest Trends: What You Should Know
• First Reliance Bancshares Delivers Strong Q3 Financial Results
• Exploring Current Market Sentiments for IonQ Inc Shares
• Bulat Utemuratov Foundation Shines at EUROBAK Awards 2025
• Micropolis Highlights Robust Growth and Strategic Innovations
• Glenmark Pharmaceuticals Unveils New Ropivacaine Injection Vials
• SuperX Invests in MicroInference to Enhance AI Ecosystem Growth
• Epomaker's 11.11 Event: Engage, Save, and Celebrate Together
• Future Form Manufacturing: Expanding Innovation in Production
• HeyGears Introduces Reflex 2 Series: A New Era in 3D Printing
• HeyGears Unveils Reflex 2 Series: Revolutionizing 3D Production
• FT Portfolios Canada Co. Reveals Upcoming Cash Distributions
• Volcan Compañía Minera S.A.A. Seeks Notes Buyback Amid Success
• Unity Against Hate: Upcoming Rally in Toronto This Weekend
• Allied Gold Secures C$175 Million in New Equity Offering
• SuperX AI and Chengtian Weiye Unite for Innovative Cooling Tech
• Lake Shore Bancorp Ups Dividend with Bright Future Ahead
• ROTH and Sustain SoCal Team Up for Virtual Sustainability Event
• Azumi Partners with DIAFA for Bold Global Expansion Strategy
• Global ELISA Market Projected Growth and Innovations Ahead
• Investors of Semler Scientific, Inc. Urged to Join Class Action
• Surging Demand in Luxury Cars: A Market Overview
• Projected Growth of the Copper Products Market to 2035
• Baxter International Faces Class Action Over Securities Fraud
• Robin Energy Ltd. Secures $7 Million in Latest Offering
• Micropolis Boosts Innovation in Robotics and AI Solutions
• Understanding the Tronox Holdings Class Action Lawsuit Impact
• eXp Realty's Innovative Tech Showcase Fuels Global Expansion
• SkyTech Orion: Innovating the Future of Defense Technology
• Fortinet Investors Alerted to Class Action Requirements and Details
• BioLab Holdings, Inc. Partners in Cold Atmospheric Plasma Innovation
• V.F. Corporation Shareholders Urged to Act Promptly
• Jackbit Casino: A New Era of Instant Withdrawals for Players
• Ro Launches Groundbreaking Scale to Measure Food Noise Effectively
• BAM Capital Strengthens Portfolio with Hayden Flats Acquisition
• Fannie Mae Reports on Home Price Trends for Q3 2025
• Essendant and Hub Group Team Up for Rapid Warehouse Deliveries
• Market Insights: Trading Strategies for SPY and Major Tech Firms
• Fluor Corporation Faces Class Action Lawsuit: What Investors Should Know
• Understanding the aTyr Pharma Lawsuit and Legal Options Ahead